Premium Nahrungsergänzungsmittel | artgerecht

Copeptin – Biomarker for Heart Attack & Diabetes Insipidus

Copeptin is a biomarker released from the pituitary gland, used in the early diagnosis of heart attack and diabetes insipidus.

Regular tips about health Regular tips about health

Things worth knowing about "Copeptin"

Copeptin is a biomarker released from the pituitary gland, used in the early diagnosis of heart attack and diabetes insipidus.

What is Copeptin?

Copeptin is a prohormone fragment produced together with antidiuretic hormone (ADH, also known as vasopressin) from a shared precursor molecule called pre-pro-vasopressin in the hypothalamus. It is stored in the pituitary gland and released into the bloodstream in response to stress, volume depletion, or changes in blood osmolality. Because copeptin is more stable and easier to measure in the blood than ADH itself, it serves as an indirect surrogate marker for ADH secretion.

Biological Function

Copeptin does not appear to have a known independent hormonal function of its own. Its medical value lies primarily in the fact that it reliably reflects the activity of the ADH system. ADH (vasopressin) regulates the body's water balance by promoting water reabsorption in the kidneys and influencing blood pressure. Copeptin is released in elevated amounts during:

Physical or emotional stress
Cardiovascular events (e.g., heart attack)
Volume depletion (dehydration, shock)
Osmotic changes in the blood
Severe infections or sepsis

Clinical Significance as a Biomarker

Heart Attack Diagnosis

One of the most important clinical applications of copeptin is the early diagnosis of acute myocardial infarction (heart attack). During a heart attack, copeptin levels rise sharply within the first hours after the event — even before the classic cardiac marker troponin reaches its peak. Combining copeptin with troponin therefore enables a faster rule-out of heart attack in the emergency department, significantly reducing diagnostic time and avoiding unnecessary hospital admissions.

Diabetes Insipidus

Copeptin also plays a central role in the differential diagnosis of diabetes insipidus, a condition in which the kidneys produce large quantities of diluted urine. The traditional diagnosis required a cumbersome water deprivation test. More recent studies have shown that measuring copeptin after stimulation with arginine (intravenous arginine infusion) can replace or supplement the water deprivation test, making the process safer and more comfortable for patients.

Further Clinical Applications

Elevated copeptin levels have also been observed and are being studied in the following conditions:

Heart failure — as a marker of disease severity and prognosis
Sepsis and critical illness — as an indicator of the stress response of the organism
Stroke — as a prognostic marker for disease outcome
Kidney disease — in connection with renal function and water balance regulation

Measurement and Reference Values

Copeptin is measured from a simple blood sample using an immunological test method (immunoassay). Reference values may vary slightly between laboratories. Typical normal values in healthy adults are below 10 pmol/l. In acute myocardial infarction, values may rise significantly above this threshold. A low copeptin level may indicate central diabetes insipidus, in which ADH production is impaired.

Advantages Over ADH Measurement

Although copeptin is only an indirect marker of the ADH system, it offers several key advantages over direct ADH measurement:

Greater stability in blood samples (ADH is highly unstable and degrades rapidly)
More reliable and straightforward laboratory measurement
No special sample handling required
Results available quickly, even in emergency settings

References

Morgenthaler N.G. et al. – Copeptin: a measure of perioperative stress and postoperative outcome. Endocrine, 2018.
Fenske W. et al. – A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus. New England Journal of Medicine, 2018.
Keller T. et al. – Sensitive troponin I assay in early diagnosis of acute myocardial infarction. New England Journal of Medicine, 2009.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.